$0.60
+0.07 (+13.99%)
Open$0.52
Previous Close$0.53
Day High$0.62
Day Low$0.50
52W High$4.33
52W Low$0.38
Volume—
Avg Volume1.28M
Market Cap11.30M
P/E Ratio—
EPS$-1.73
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+523.5% upside
Current
$0.60
$0.60
Target
$3.76
$3.76
$2.62
$3.76 avg
$5.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.84M | 7.68M | 7.81M |
| Net Income | -2,005,672 | -1,738,578 | -1,581,297 |
| Profit Margin | -25.6% | -22.6% | -20.2% |
| EBITDA | -2,263,216 | -2,551,790 | -2,649,024 |
| Free Cash Flow | -1,406,564 | -1,071,377 | -1,645,390 |
| Rev Growth | +12.8% | +0.1% | +6.4% |
| Debt/Equity | 0.17 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |